Skip to main content
SpringerLink
Log in

Case-Control Studies & the Hierarchy of Study Design

  • Invited Commentary
  • Published:
Current Epidemiology Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Doll R, Hill AB. Smoking and carcinoma of the lung; preliminary report. Br Med J. 1950;2:739–48.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Maclure M. The case-crossover design: a method for studying transient effects on the risk of acute events. Am J Epidemiol. 1991;133:144–53.

    CAS  PubMed  Google Scholar 

  3. Suissa S. The case-time-control design. Epidemiology. 1995;6:248–53.

    Article  CAS  PubMed  Google Scholar 

  4. Fletcher RH, Fletcher SW, Fletcher GS. Clinical epidemiology, page 206. The essentials. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2014.

    Google Scholar 

  5. Rothman KJ, Greenland S, Lash TL. Modern Epidemiology. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2008.

    Google Scholar 

  6. Feinstein AR. Clinical biostatistics. XX. The epidemiologic trohoc, the ablative risk ratio, and “retrospective” research. Clin Pharmacol Ther. 1973;14:291–307.

    Article  CAS  PubMed  Google Scholar 

  7. Guyatt GH, Sackett DL, Sinclair JC, Hayward R, Cook DJ, Cook RJ. Users’ guides to the medical literature. IX. A method for grading health care recommendations. JAMA. 1995;274:1800–4.

    Article  CAS  PubMed  Google Scholar 

  8. Acute myocardial infarction and combined oral contraceptives: results of an international multicentre case-control study. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Lancet. 1997;349:1202–9.

  9. Lukic M, Licaj I, Lund E, Skeie G, Weiderpass E, Braaten T. Coffee consumption and the risk of cancer in the Norwegian Women and Cancer (NOWAC) Study. Eur J Epidemiol. 2016;31:905–16.

    Article  CAS  PubMed  Google Scholar 

  10. Dewi NU, Boshuizen HC, Johansson M, Vineis P, Kampman E, Steffen A, Tjønneland A, Halkjær J, Overvad K, Severi G, Fagherazzi G, Boutron-Ruault MC, Kaaks R, Li K, Boeing H, Trichopoulou A, Bamia C, Klinaki E, Tumino R, Palli D, Mattiello A, Tagliabue G, Peeters PH, Vermeulen R, Weiderpass E, Torhild Gram I, Huerta JM, Agudo A, Sánchez MJ, Ardanaz E, Dorronsoro M, Quirós JR, Sonestedt E, Johansson M, Grankvist K, Key T, Khaw KT, Wareham N, Cross AJ, Norat T, Riboli E, Fanidi A, Muller D, Bueno-de-Mesquita HB. Anthropometry and the Risk of Lung Cancer in EPIC. Am J Epidemiol. 2016;184:129–39.

    Article  PubMed  Google Scholar 

  11. Ganna A, Ingelsson E. 5 year mortality predictors in 498,103 UK Biobank participants: a prospective population-based study. Lancet. 2015;386:533–40.

    Article  PubMed  Google Scholar 

  12. Tjønneland A, Olsen A, Boll K, Stripp C, Christensen J, Engholm G, Overvad K. Study design, exposure variables, and socioeconomic determinants of participation in diet, cancer and health: a population-based prospective cohort study of 57,053 men and women in Denmark. Scand J Public Health. 2007;35:432–41.

    Article  PubMed  Google Scholar 

  13. Ardisson Korat AV, Willett WC, Hu FB. Diet, lifestyle, and genetic risk factors for type 2 diabetes: a review from the nurses’ health study, nurses’ health study 2, and health professionals’ follow-up study. Curr Nutr Rep. 2014;3:345–54.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Siscovick DS, Weiss NS, Fletcher RH, Lasky T. The incidence of primary cardiac arrest during vigorous exercise. N Engl J Med. 1984;311:874–7.

    Article  CAS  PubMed  Google Scholar 

  15. Erichsen R, Baron JA, Hamilton-Dutoit SJ, Snover DC, Torlakovic EE, Pedersen L, Frøslev T, Vyberg M, Hamilton SR, Sørensen HT. Increased risk of colorectal cancer development among patients with serrated polyps. Gastroenterology. 2016;150:895–902.

    Article  PubMed  Google Scholar 

  16. Rockenbauer M, Olsen J, Czeizel AE, Pedersen L, Sørensen HT, EuroMAP Group. Recall bias in a case-control surveillance system on the use of medicine during pregnancy. Epidemiology. 2001;12:461–6.

    Article  CAS  PubMed  Google Scholar 

  17. McGlynn KA, Hagberg K, Chen J, Graubard BI, London WT, Jick S, Sahasrabuddhe VV. Statin use and risk of primary liver cancer in the Clinical Practice Research Datalink. J Natl Cancer Inst. 2015;107(4).

  18. Bloemenkamp KW, Rosendaal FR, Helmerhorst FM, Büller HR, Vandenbroucke JP. Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen. Lancet. 1995;346:1593–6.

    Article  CAS  PubMed  Google Scholar 

  19. Jick H, Derby LE, Myers MW, Vasilakis C, Newton KM. Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogens. Lancet. 1996;348:981–3.

    Article  CAS  PubMed  Google Scholar 

  20. Robertson DJ, Larsson H, Friis S, Pedersen L, Baron JA, Sørensen HT. Proton pump inhibitor use and risk of colorectal cancer: a population-based, case-control study. Gastroenterology. 2007;133:755–60.

    Article  PubMed  Google Scholar 

  21. Michaëlsson K, Baron JA, Farahmand BY, Persson I, Ljunghall S. Oral-contraceptive use and risk of hip fracture: a case-control study. Lancet. 1999;353:1481–4.

    Article  PubMed  Google Scholar 

  22. Farahmand BY, Michaëlsson K, Ahlbom A, Ljunghall S, Baron JA, Swedish Hip Fracture Study Group. Survival after hip fracture. Osteoporos Int. 2005;16:1583–90.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark

    Henrik Toft Sørensen

Authors
  1. Henrik Toft Sørensen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Henrik Toft Sørensen.

Ethics declarations

Conflict of Interest

Henrik Toft Sørensen declares that he has no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sørensen, H.T. Case-Control Studies & the Hierarchy of Study Design. Curr Epidemiol Rep 3, 262–264 (2016). https://doi.org/10.1007/s40471-016-0091-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40471-016-0091-7

Keywords

Search

Navigation